The emerging treatment of this peptide represents a major breakthrough in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide619558.mdkblog.com/48182642/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment